A
AngioWave
AI-powered medical imaging for vascular structures visualization
About AngioWave
AngioWave is a healthcare technology company that develops AI-powered, post-processing medical technology to enhance the visualization of vascular structures during angiographic procedures. The company's core product, AngioWaveNet, is software that automatically processes radiological images to help clinicians analyze them more efficiently. This platform integrates with existing fluoroscopic angiography systems to provide clearer imaging, which assists cardiologists in diagnosing conditions like coronary artery disease more effectively and with a lower radiation dose.
The company's technology is designed to improve clinical decision-making and patient outcomes by offering a minimally invasive approach. It has been involved in clinical trials to evaluate radiation reduction in heart imaging procedures. Founded in 2020, AngioWave is a private company backed by institutional investor DRADS Capital and has raised at least $8.33M in funding. The company's focus is on aiding cardiologists and patients with symptomatic peripheral artery disease (PAD) by improving blood flow through the stimulation of new blood vessel growth and removal of micro-plaque.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Concord, United States
- Employees
- 6
- Open positions
- None listed
- Dealroom signal
- 80.3/100
- Industry
- Health
- Sub-industry
- Medical Devices, Health Platform
- Sector
- Health Tech & Medtech, Radiology, Medical Imaging, Spinout, AI for medical imaging, DT and LS
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning, Deep Learning
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Feb 2026 | $10M | $40M | Undisclosed | ↗ |
| SERIES AOther financing | Jan 2023 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for AngioWave is 50 monthly website visits. AngioWave's team grew 50% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
Massachusetts General Hospital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about AngioWave on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AngioWave’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.